Skip to content

Translational Data to Guide Clinical Development & Target Discovery

Time: 11:15 am
day: Day One


• Human disease derived data are discussed vis a vis in-vitro model systems and animal models
• Examples are provided from GBR 830 program, an OX40/OX40L pathway blocking antibody in Ph2b development in Atopic Dermatitis